Noami Chaudhary

Dr. Noami Chaudhary


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in The Cancer Journal
Verified
Journal Article
Closed access
LYLiying Yang
Liying Yang
NCNoami Chaudhary
Noami Chaudhary
JBJonathan Baghdadi
Jonathan Baghdadi
ZPZhiheng Pei
Zhiheng Pei
The incidence of esophageal adenocarcinoma has increased dramatically in the United States and Europe since the 1970s without apparent cause. Although specific host factors can affect risk of disease, such a rapid increase in incidence must be predominantly environmental. In the stomach, infection with Helicobacter pylori has been linked to chronic atrophic gastritis, an inflammatory precursor of gastric adenocarcinoma. However, the role of H. pylori in the development of esophageal adenocarcinoma is not well established. Meanwhile, several studies have established that a complex microbiome in the distal esophagus might play a more direct role. Transformation of the microbiome in precursor states to esophageal adenocarcinoma—reflux esophagitis and Barrett metaplasia—from a predominance of gram-positive bacteria to mostly gram-negative bacteria raises the possibility that dysbiosis is contributing to pathogenesis. However, knowledge of the microbiome in esophageal adenocarcinoma itself is lacking. Microbiome studies open a new avenue to the understanding of the etiology and pathogenesis of reflux disorders.

1 December 2014 in Clinics In Laboratory Medicine
Verified
Journal Article
Closed access
JBJonathan Baghdadi
Jonathan Baghdadi
NCNoami Chaudhary
Noami Chaudhary
ZPZhiheng Pei
Zhiheng Pei
LYLiying Yang
Liying Yang

Verified
Journal Article
Open access
PDF file
JMJonathan Merola
Jonathan Merola
NCNoami Chaudhary
Noami Chaudhary
MQMeng Qian
Meng Qian
AJAlexander Jow
Alexander Jow
KBKatherine Barboza
Katherine Barboza
SSSamuel Sigal
Samuel Sigal
Hepatic encephalopathy (HE) is a frequent complication in cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt (TIPS). Hyponatremia (HN) is a known contributing risk factor for the development of HE. Predictive factors, especially the effect of HN, for the development of overt HE within one week of TIPS placement were assessed. A single-center, retrospective chart review of 71 patients with cirrhosis who underwent TIPS creation from 2006–2011 for non-variceal bleeding indications was conducted. Baseline clinical and laboratory characteristics were collected. Factors associated with overt HE within one week were identified, and a multivariate model was constructed. Seventy one patients who underwent 81 TIPS procedures were evaluated. Fifteen patients developed overt HE within one week. Factors predictive of overt HE within one week included pre-TIPS Na, total bilirubin and Model for End-stage Liver Disease (MELD)-Na. The odds ratio for developing HE with pre-TIPS Na <135 mEq/L was 8.6. Among patients with pre-TIPS Na <125 mEq/L, 125–129.9 mEq/L, 130–134.9 mEq/L and ≥135 mEq/L, the incidence of HE within one week was 37.5%, 25%, 25% and 3.4%, respectively. Lower pre-TIPS Na, higher total bilirubin and higher MELD-Na values were associated with the development of overt HE post-TIPS within one week. TIPS in hyponatremic patients should be undertaken with caution.

1 July 2017 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
NCNoami Chaudhary
Noami Chaudhary
CLCatherine Lucero
Catherine Lucero
GVGerald Villanueva
Gerald Villanueva
MPMichael Poles
Michael Poles
CGColleen Gillespie
Colleen Gillespie
EWElizabeth Weinshel
Elizabeth Weinshel

1 June 2018 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
PDF file
JMJonathan Merola
Jonathan Merola
BFBrett E. Fortune
Brett E. Fortune
YDYanhong Deng
Yanhong Deng
MCMaria Ciarleglio
Maria Ciarleglio
SASmbat Amirbekian
Smbat Amirbekian
SSSamuel H. Sigal
Samuel H. Sigal
Portal vein thrombosis (PVT) develops in cirrhotic patients because of stagnation of blood flow. Transjugular intrahepatic portosystemic shunt (TIPS) creates a low-resistance conduit that restores portal venous patency and blood flow. The effect of PVT on transplant-free survival in cirrhotic patients undergoing TIPS creation was evaluated. A multicenter, retrospective cohort study of patients who underwent TIPS creation for cirrhotic portal hypertension was carried out. A Cox model with propensity score adjustment was developed to evaluate the effect of PVT on 90-day and 3-year transplant-free survival. A subgroup analysis examining mortality of those with superior and distal PVT was also carried out. A total of 252 consecutive TIPS creations were assessed, including 65 in patients with PVT. Survival of patients with high Model for End-stage Liver Disease scores (≥18) and PVT was not statistically different compared with patients with low Model for End-stage Liver Disease scores (<18) and no PVT at 90 days (P=0.46) and 3 years (P=0.42). Those with inferior PVT had improved 90-day and 3-year survival both compared with patients with a superior PVT and those without a PVT (P<0.01, all cases). The presence of PVT does not impair the prognosis of patients following TIPS creation, particularly in patients with distal portal occlusion.

1 February 2017 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
MYM Yuhasz
M Yuhasz
EME Morris
E Morris
JMJ Merola
J Merola
NCNoami Chaudhary
Noami Chaudhary
SSS Sigal
S Sigal
EAE Aaltonen
E Aaltonen